PKC-β controls IκB kinase lipid raft recruitment and activation in response to BCR signaling-Reference-Cited by-同舟云学术

PKC-β controls IκB kinase lipid raft recruitment and activation in response to BCR signaling

Published:2002-07-15 Issue:8 Volume:3 Page:780-786
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Su Thomas T.,Guo Beichu,Kawakami Yuko,Sommer Karen,Chae Keun,Humphries Lisa A.,Kato Roberta M.,Kang Shin,Patrone Lisa,Wall Randolph,Teitell Michael,Leitges Michael,Kawakami Toshiaki,Rawlings David J.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni823.pdf

Reference48 articles.

1. Karin, M. & Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18, 621–663 (2000).

2. Ghosh, S., May, M.J. & Kopp, E.B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225–260 (1998).

3. Bendall, H.H., Sikes, M.L., Ballard, D.W. & Oltz, E.M. An intact NF-κB signaling pathway is required for maintenance of mature B cell subsets. Mol. Immunol. 36, 187–195 (1999).

4. Kaisho, T. et al. IκB kinase α is essential for mature B cell development and function. J. Exp. Med. 193, 417–426 (2001).

5. Senftleben, U. et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293, 1495–1499 (2001).

Cited by 286 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and validation of immune‐related methylated genes as diagnostic and prognostic biomarkers of nasopharyngeal carcinoma;Head & Neck;2023-11-06

2. C-Reactive Protein Signaling Pathways in Tumor Progression;Biomolecules & Therapeutics;2023-08-11

3. Hepatic protein kinase Cbeta deficiency mitigates late-onset obesity;Journal of Biological Chemistry;2023-08

4. Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response;Biology;2023-07-26

5. Targeting NF ‐κB in Oncology, an Untapped Therapeutic Potential;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15